Psychiatry and Neurology, Neurology · New York, NY
NPI
1538193800
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
10 Union Sq E
New York, NY, 10003
Phone (212) 844-6910
Groups this clinician bills Medicare through
Medicare paid, 2024
$71K
1,079 services
Medicare patients, 2024
386
Average age 76
Drug cost, 2024
$458K
2,708 prescriptions
Company payments, 2023
$107
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David M Swope was code 99214 (office e&m - established), 531 times for 255 patients. In total David M Swope billed 1,079 services in 17 codes, and Medicare paid $71K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-06-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 531 | 255 | $74.64 | $40K |
| 99205 Office E&M - New | Office | 122 | 122 | $136.16 | $17K |
| 99213 Office E&M - Established | Office | 49 | 42 | $43.13 | $2,113 |
| 99215 Office E&M - Established | Office | 49 | 49 | $110.83 | $5,430 |
| 99442 Telephone Services | Office | 23 | 21 | $52.02 | $1,197 |
By year: 2022 $89K for 1,364 services; 2023 $92K for 2,536 services; 2024 $71K for 1,079 services.
Medicare prescription drug claims, 2024
In 2024, the drug David M Swope prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 783 prescriptions and refills. In total David M Swope wrote 2,708 Medicare prescriptions that cost $458K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 783 | 1,420 | 176 | $27K |
| Rasagiline Mesylate Generic | 355 | 576 | 89 | $54K |
| Donepezil Hcl Generic | 277 | 520 | 87 | $2,498 |
| Primidone Generic | 223 | 401 | 56 | $4,928 |
| Amantadine Amantadine Hcl | 178 | 317 | 61 | $9,333 |
| Zonisamide Generic | 139 | 230 | 45 | $4,314 |
| Propranolol Hcl Generic | 111 | 193 | 27 | $1,895 |
| Rytary Carbidopa/Levodopa | 92 | 140 | 14 | $100K |
| Gabapentin Generic | 61 | 90 | 23 | $810 |
| Entacapone Generic | 58 | 104 | 16 | $20K |
| Baclofen Generic | 43 | 56 | 13 | $1,318 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 37 | 89 | 13 | $700 |
| Quetiapine Fumarate Generic | 31 | 40 | Under 11 | $442 |
| Pramipexole Er Pramipexole Di-Hcl | 28 | 38 | Under 11 | $4,888 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 28 | 66 | Under 11 | $1,557 |
Brand drugs: 211 claims; generic drugs: 2,497 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid David M Swope $107 ($107 in general payments such as food, travel and fees) from 1 company. The largest payer was Acorda Therapeutics, Inc with $107.
| Company | Payments | Amount |
|---|---|---|
| Acorda Therapeutics, Inc | 1 | $107 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.